Personal information

Other IDs

ResearcherID: K-4113-2015

Activities

Collapse all

Employment (6)

University of Central Lancashire: Preston, GB

Employment
Source: check_circle
University of Central Lancashire

Heinrich-Heine-Universität Düsseldorf Medizinische Fakultät: Dusseldorf, Nordrhein-Westfalen, DE

2018-10-01 to present (Department of Molecular Medicine II)
Employment
Source: Self-asserted source
Mazin Al-Salihi

University of Jordan: Amman, JO

2014-09-01 to 2017-08-01 | Assistant Professor (Pathology)
Employment
Source: Self-asserted source
Mazin Al-Salihi

university of dundee: Dundee, Dundee, GB

2010 to 2013 | Career Development Fellow (MRC Protein Phosphorylation and Ubiquitylation Unit )
Employment
Source: Self-asserted source
Mazin Al-Salihi

University of Utah: Salt Lake City, UT, US

2008 to 2010 | Postdoctoral Research Fellow (Huntsman Cancer Institute)
Employment
Source: Self-asserted source
Mazin Al-Salihi

University of Utah: Salt Lake City, UT, US

2003 to 2008 | Graduate Research Assistant (Molecular Biology)
Employment
Source: Self-asserted source
Mazin Al-Salihi

Education and qualifications (2)

University of Utah: Salt Lake City, UT, US

2003-07-01 to 2008-02-22 | Ph.D. (Molecular Biology)
Education
Source: Self-asserted source
Mazin Al-Salihi

University of Jordan: Amman, JO

1995-09-01 to 2001-05-21 | MBBS (Medicine)
Education
Source: Self-asserted source
Mazin Al-Salihi

Works (11)

iRhom2: An Emerging Adaptor Regulating Immunity and Disease

International Journal of Molecular Sciences
2020-09-08 | Journal article
DOI: 10.3390/ijms21186570
Contributors: Mazin A. Al-Salihi; Philipp A. Lang
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

iRhom2 inhibits bile duct obstruction–induced liver fibrosis

Science Signaling
2019-10-29 | Journal article
DOI: 10.1126/scisignal.aax1194
Contributors: Balamurugan Sundaram; Kristina Behnke; Andrea Belancic; Mazin A. Al-Salihi; Yasser Thabet; Robin Polz; Rossella Pellegrino; Yuan Zhuang; Prashant V. Shinde; Haifeng C. Xu et al.
Source: check_circle
Crossref

The effect of platelet lysate in culture of PDLSCs: an in vitro comparative study.

PeerJ
2019-08 | Journal article
DOI: 10.7717/peerj.7465
PMID: 31410313
PMC: PMC6689390
Contributors: Abuarqoub DA; Aslam N; Barham RB; Ababneh NA; Shahin DA; Al-Oweidi AA; Jafar HD; Al-Salihi MA; Awidi AS
Source: Self-asserted source
Mazin Al-Salihi via Europe PubMed Central

Influence of myeloperoxidase on colon tumor occurrence in inflamed versus non-inflamed colons of Apc(Min/+) mice.

2015-07 | Journal article
DOI: 10.1016/j.redox.2015.07.013
PMID: 26262998
PMC: PMC4536298
Contributors: Al-Salihi M; Reichert E; Fitzpatrick FA
Source: Self-asserted source
Mazin Al-Salihi via Europe PubMed Central

USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling.

2014-05 | Journal article
DOI: 10.1098/rsob.140065
PMID: 24850914
PMC: PMC4042855
Contributors: Herhaus L; Al-Salihi MA; Dingwell KS; Cummins TD; Wasmus L; Vogt J; Ewan R; Bruce D; Macartney T; Weidlich S et al.
Source: Self-asserted source
Mazin Al-Salihi via Europe PubMed Central

OTUB1 enhances TGFβ signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3.

2013 | Journal article
DOI: 10.1038/ncomms3519
PMID: 24071738
PMC: PMC3791481
Contributors: Herhaus L; Al-Salihi M; Macartney T; Weidlich S; Sapkota GP
Source: Self-asserted source
Mazin Al-Salihi via Europe PubMed Central

USP11 augments TGFβ signalling by deubiquitylating ALK5.

2012-06 | Journal article
DOI: 10.1098/rsob.120063
PMID: 22773947
PMC: PMC3390794
Contributors: Al-Salihi MA; Herhaus L; Macartney T; Sapkota GP
Source: Self-asserted source
Mazin Al-Salihi via Europe PubMed Central

Regulation of the transforming growth factor β pathway by reversible ubiquitylation.

2012-05 | Journal article
DOI: 10.1098/rsob.120082
PMID: 22724073
PMC: PMC3376735
Contributors: Al-Salihi MA; Herhaus L; Sapkota GP
Source: Self-asserted source
Mazin Al-Salihi via Europe PubMed Central

The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2'deoxycytidine (decitabine) are differentially regulated by cell cycle progression.

2011-08 | Journal article
DOI: 10.4161/epi.6.8.16064
PMID: 21725200
PMC: PMC3359489
Contributors: Al-Salihi M; Yu M; Burnett DM; Alexander A; Samlowski WE; Fitzpatrick FA
Source: Self-asserted source
Mazin Al-Salihi via Europe PubMed Central

Transgenic expression of cyclooxygenase-2 in mouse intestine epithelium is insufficient to initiate tumorigenesis but promotes tumor progression.

2009-01 | Journal article
DOI: 10.1016/j.canlet.2008.08.012
PMID: 18790560
PMC: PMC2646674
Contributors: Al-Salihi MA; Terrece Pearman A; Doan T; Reichert EC; Rosenberg DW; Prescott SM; Stafforini DM; Topham MK
Source: Self-asserted source
Mazin Al-Salihi via Europe PubMed Central

Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme.

2007-09 | Journal article
DOI: 10.1016/j.cellsig.2007.05.003
PMID: 17572069
PMC: PMC2681182
Contributors: Al-Salihi MA; Ulmer SC; Doan T; Nelson CD; Crotty T; Prescott SM; Stafforini DM; Topham MK
Source: Self-asserted source
Mazin Al-Salihi via Europe PubMed Central
How many people are using ORCID?